| Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial P Tebas, SP Yang, JD Boyer, EL Reuschel, A Patel, A Christensen-Quick, ... EClinicalMedicine 31, 2021 | 252 | 2021 |
| Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ B Astry, SH Venkatesha, A Laurence, A Christensen-Quick, ... Clinical immunology 157 (2), 228-238, 2015 | 126 | 2015 |
| Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection A Christensen-Quick, M Lafferty, L Sun, L Marchionni, A DeVico, ... Journal of virology 90 (17), 7833-7847, 2016 | 72 | 2016 |
| Cytomegalovirus and HIV persistence: pouring gas on the fire A Christensen-Quick, C Vanpouille, A Lisco, S Gianella AIDS Research and Human Retroviruses 33 (S1), S-23-S-30, 2017 | 65 | 2017 |
| Dynein-dependent nuclear dynamics affect morphogenesis in Candida albicans by means of the Bub2p spindle checkpoint KR Finley, KJ Bouchonville, A Quick, J Berman Journal of Cell Science 121 (4), 466-476, 2008 | 52 | 2008 |
| Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at … MP Mammen Jr, P Tebas, J Agnes, M Giffear, KA Kraynyak, E Blackwood, ... MedRxiv, 2021.05. 07.21256652, 2021 | 49 | 2021 |
| INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants VM Andrade, A Christensen-Quick, J Agnes, J Tur, C Reed, R Kalia, ... npj Vaccines 6 (1), 121, 2021 | 42 | 2021 |
| SARS-CoV-2 DNA vaccine INO-4800 induces durable immune responses capable of being boosted in a phase 1 open-label trial KA Kraynyak, E Blackwood, J Agnes, P Tebas, M Giffear, D Amante, ... The Journal of infectious diseases 225 (11), 1923-1932, 2022 | 41 | 2022 |
| Subclinical cytomegalovirus DNA is associated with CD4 T cell activation and impaired CD8 T cell CD107a expression in people living with HIV despite early antiretroviral therapy A Christensen-Quick, M Massanella, A Frick, SA Rawlings, C Spina, ... Journal of virology 93 (13), 10.1128/jvi. 00179-19, 2019 | 35 | 2019 |
| Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6+CD4+ T Cells MK Lafferty, L Sun, A Christensen-Quick, W Lu, A Garzino-Demo Viruses 9 (5), 111, 2017 | 26 | 2017 |
| Effect of cannabis use on human immunodeficiency virus DNA during suppressive antiretroviral therapy A Chaillon, M Nakazawa, C Anderson, A Christensen-Quick, RJ Ellis, ... Clinical Infectious Diseases 70 (1), 140-143, 2020 | 24 | 2020 |
| Influenza vaccination can broadly activate the HIV reservoir during antiretroviral therapy A Christensen-Quick, A Chaillon, C Yek, F Zanini, P Jordan, C Ignacio, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 79 (3), e104-e107, 2018 | 20 | 2018 |
| Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of an open-label, Phase 1 clinical trial, EClinicalMedicine 31 (2021), 100689 P Tebas, S Yang, JD Boyer, EL Reuschel, A Patel, A Christensen-Quick, ... | 9 | 2020 |
| INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants. NPJ Vaccines 6: 121 VM Andrade, A Christensen-Quick, J Agnes, J Tur, C Reed, R Kalia, ... | 7 | 2021 |
| 571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster P Tebas, J Agnes, M Giffear, KA Kraynyak, E Blackwood, D Amante, ... Open Forum Infectious Diseases 8 (Supplement_1), S387-S388, 2021 | 1 | 2021 |
| 578. INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants VM Andrade, A Christensen-Quick, J Agnes, J Tur, CC Reed, R Kalia, ... Open Forum Infectious Diseases 8 (Supplement_1), S390-S391, 2021 | | 2021 |
| Seeking career clarity C Antoniou, K Burnette, A Christensen-Quick, M Lewinska, Y Ji, ... Science 368 (6486), 26-28, 2020 | | 2020 |
Sara Gianella WeibelAssociate Professor of Medicine, University of California San Diego在 ucsd.edu 的电子邮件经过验证
